GB1473148A
Expires 1977-05-11 · 49y expired
What this patent protects
1473148 Platinum-containing derivatives of uracil RESEARCH CORP 16 Sept 1974 40175/74 Heading C2C The invention comprises complexes prepared by reacting at 0-55‹ C., 1 mole of cis-diaquodiammineplatinum (II) with 1-2 moles of a compound of formula or its 5,6-dihydro derivative, w…
USPTO Abstract
1473148 Platinum-containing derivatives of uracil RESEARCH CORP 16 Sept 1974 40175/74 Heading C2C The invention comprises complexes prepared by reacting at 0-55‹ C., 1 mole of cis-diaquodiammineplatinum (II) with 1-2 moles of a compound of formula or its 5,6-dihydro derivative, wherein R 1 and R 2 are each H, alkyl, dialkylamino, di(haloalkyl)- amino, halogen, OH, hydroxyalkyl or carboalkoxy, and R 3 and R 4 are each H, alkylribosyl, deoxyribosyl, ribosyl, triacetyl-, tribenzoyl- or 2<SP>1</SP>,3<SP>1</SP>-alkylideneribosyl, ribosyl phosphates or deoxyribosyl phosphates. Therapeutic compositions for treating cancer or bacterial or viral infections comprise the above complexes, and may be administered orally or parenterally.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.